Popular Articles

June Is Brain Injury Awareness Month In Canada
Brain injuries are the number one killer and disabler of people under the age of 45 in Canada. These injuries are

Patients With Rheumatoid Arthritis Who Had Poor Response To Other Drugs Could Have Better Results With Golimumab
An article published Online First and in this week"s edition of reports information about Golimumab, a new tumour necrosis factor-í± (TNF-í±) inhibitor. It reduces the signs and symptoms of rheumatoid arthritis in patients who have previously received any other TNF-í± inhibitor. This drug might be a good alternative for patients who have inadequate responses to one or two other TNF-í± inhibitors.
News of the day
Racial Disparities In Breast Cancer Mortality Are Not Driven By Estrogen Receptor Status Alone
Black women who are diagnosed with breast cancer have a higher probability of dying from the disease than white women, regardless of their estrogen receptor status, according to research from the National Cancer Institute (NCI), part of the National Institutes of Health. Differences in breast cancer mortality may reflect racial differences in access and response to innovative breast cancer treatments, as well as other biological and non-biological factors, according to the report. In addition, the researchers found that differences in outcomes in the first few years post-diagnosis make up nearly all of the disparity. These results were published online July 7, 2009 in the Journal of the National Cancer Institute.
Diagnostics

Health Lobbying Means Cash Infusion For Candidates, TV StationsKaiser

"Health care groups working feverishly to shape -- or kill -- an industry-wide reform bill are lavishing campaign cash on the politicians at the center of the debate," The Salt Lake (Utah) Tribune reports. Sens. Orrin Hatch and Max Baucus, both major health reform players on the Senate Finance Committee, are among those benefiting form the uptick in contributions. One lobbyist for the watchdog group Public Citizen said, "A person can reach no other conclusion than this is quid pro quo activity" (Canham, 7/27). In the second quarter of this year, groups spent $257.5 million, CQ Politics reports. That number shows "the breadth of interest in the issue. Those lobbying Congress and federal officials on health care include banks, high-tech companies, automobile manufacturers and oil companies, as well as hospitals, doctors" groups and drug companies." Various campaigns by advocacy groups in particular seek to push or derail reform efforts (Roth and Knott, 7/26). The lobbying is also shaping unusual alliances. Service Employees International Union President Andy Stern, for instance, has cultivated a relationship with Wal-Mart, which he is leveraging to gain attention in Washington, the Wall Street Journal reports. SEIU and Wal-Mart sent a joint letter to the White House last month, drawing attention because the workers and the major employer have previously clashed over labor issues. "Mr. Stern said the Wal-Mart alliance has helped open doors with lawmakers" (Trottman, 7/27). Charlotte Observer: "It"s July in a nonelection year, but the state"s political machinery is fully engaged. Rallies, phone banks and door-to-door canvassing are under way, TV commercials fill airwaves, and petitions appear beside ripe tomatoes at farmers markets." A concentration of conservative Democrats who could make or break reform efforts, as well as health industry staples like GlaxoSmithKline, make North Carolina a critical battleground for lobbyists and activists alike (Christensen, 7/26). The lobbying boom has also formed a much-needed opportunity for television stations, the Wall Street Journal reports in a separate story. "Altogether, groups on various sides of the debate have spent an average of about $1 million a day in recent weeks [on advertising meant to sway the reform debate], analysts say." The paper adds: "So far the lion"s share of dollars in the health-care debate has been spent on local-TV stations and national cable news networks, such as Time Warner"s CNN and News Corp."s Fox News" (Vranica and Mundy, 7/27). The New York Times: Meanwhile, lawmakers are seeking to fight back against some television ad campaigns. Several proposals circulating in Congress would ban some drug ads. One would outlaw ads for drugs like Viagra on decency grounds, while another would attempt to block ads because "you should not be diagnosed by some pitchman on TV," as Rep. Jerrold Nadler, D-N.Y., who introduced the bill, put it (Singer, 7/26). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):